Skip to main content

Want a detailed portfolio tracker?

Belite Bio (BLTE) P/E (2022 - 2026)

Belite Bio (BLTE) P/E from Apr 29, 2022 to Jul 21, 2026. The TTM Belite Bio (BLTE) P/E is -81.65. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Belite Bio (BLTE)

YearP/EChange
2026-81.65+0.70%
2025-81.08+45.91%
2024-55.57-38.29%
2023-90.05+181.15%
2022-32.03N/A

Comparison Belite Bio (BLTE) P/E with competitors

Belite Bio (BLTE) P/E is -81.65.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.09%
FGENFibroGen Inc0.24-100.29%
CHRSCoherus Biosciences Inc0.85-101.04%
FBIOFortress Biotech Inc0.95-101.16%
ORMPOramed Pharmaceuticals Inc1.50-101.84%
AGENAgenus Inc3.01-103.69%
INVAInnoviva Inc3.15-103.86%
VXRTVaxart Inc3.55-104.35%
CRMDCorMedix Inc3.63-104.44%
CVACCureVac N.V.4.45-105.44%
GLPGGalapagos NV4.86-105.95%
SRPTSarepta Therapeutics Inc4.88-105.98%
ABEOAbeona Therapeutics Inc5.39-106.60%
ABUSArbutus Biopharma Corp5.60-106.85%
ZVRAZevra Therapeutics Inc5.89-107.21%
SPROSpero Therapeutics Inc6.23-107.63%
CGENCompugen Ltd6.31-107.73%
RIGLRigel Pharmaceuticals6.87-108.42%
SLXNSilexion Therapeutics Corp7.30-108.94%
OMEROmeros Corporation9.26-111.34%
AUPHAurinia Pharmaceuticals Inc9.58-111.74%
PLXProtalix BioTherapeutics Inc10.89-113.34%
ACADAcadia Pharmaceuticals Inc11.73-114.36%
TBPHTheravance Biopharma Inc12.26-115.02%
ADMAAdma Biologics Inc12.42-115.21%
HRMYHarmony Biosciences Holdings Inc13.82-116.93%
SABSSAB Biotherapeutics Inc14.14-117.31%
NAGENiagen Bioscience Inc14.82-118.15%
INCYIncyte Corp15.82-119.38%
REGNRegeneron Pharmaceuticals Inc15.86-119.42%
PBYIPuma Biotechnology Inc17.32-121.21%
CPRXCatalyst Pharmaceuticals Inc17.44-121.36%
EXELExelixis Inc17.54-121.48%
TGTXTG Therapeutics Inc18.97-123.23%
MDXGMimedx Group Inc20.55-125.17%
XOMAXOMA Royalty Corp22.87-128.02%
ARGXArgen X SE24.30-129.76%
CTMXCytomX Therapeutics Inc24.82-130.40%
XOMAOXOMA Royalty Corp25.34-131.04%
HALOHalozyme Therapeutics Inc25.62-131.38%
XOMAPXOMA Royalty Corp25.67-131.44%
VRTXVertex Pharmaceuticals Inc27.99-134.29%
RPRXRoyalty Pharma plc - Class A28.69-135.13%
SLNOSoleno Therapeutics Inc29.02-135.54%
ASNDAscendis Pharma A/S30.09-136.85%
LGNDLigand Pharmaceuticals Inc - Class B37.91-146.43%
APLSApellis Pharmaceuticals Inc39.02-147.79%
BMRNBiomarin Pharmaceutical Inc42.21-151.70%
KRYSKrystal Biotech Inc45.34-155.53%
ONCBeiGene Ltd69.54-185.17%
PHARPharming Group N.V.75.03-191.89%
TECHBio-Techne Corp101.96-224.87%
VCELVericel Corp109.92-234.62%
ALNYAlnylam Pharmaceuticals Inc117.96-244.47%
GMABGenmab140.29-271.82%
TLXTelix Pharmaceuticals Ltd162.15-298.59%
CORTCorcept Therapeutics Inc212.86-360.69%